diazoxide has been researched along with Disease Exacerbation in 3 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshioka, M | 1 |
| Shibata, S | 1 |
| Uchinami, H | 1 |
| Watanabe, G | 1 |
| Miyazawa, H | 1 |
| Iida, M | 1 |
| Yoshida, M | 1 |
| Yoshioka, T | 1 |
| Nanjo, H | 1 |
| Yamamoto, Y | 1 |
| Virgili, N | 1 |
| Espinosa-Parrilla, JF | 1 |
| Mancera, P | 1 |
| Pastén-Zamorano, A | 1 |
| Gimeno-Bayon, J | 1 |
| Rodríguez, MJ | 1 |
| Mahy, N | 1 |
| Pugliese, M | 1 |
| Karlsson, FA | 1 |
| Björk, E | 1 |
1 review available for diazoxide and Disease Exacerbation
| Article | Year |
|---|---|
Beta-cell rest: a strategy for the prevention of autoimmune diabetes.
Topics: Autoantibodies; Autoantigens; Diabetes Mellitus, Type 1; Diazoxide; Disease Progression; Gene Expres | 1997 |
2 other studies available for diazoxide and Disease Exacerbation
| Article | Year |
|---|---|
The transformation of a nonfunctioning islet cell tumor of the pancreas into a proinsulinoma under conditions of lung metastasis.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Is | 2015 |
Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Cell Line; Diazoxi | 2011 |